# Dare Bioscience, Inc. (DARE)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/DARE/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 152.5K | $ -3.00M | $ -5.52M | $ 1.61M | $ 734.5K |
| 2025 | $ 1.05M | $ -13.72M | $ -10.52M | $ 2.66M | $ 2.84M |
| 2024 | $ 10.3K | $ -4.26M | $ 5.07M | $ 1.30M | $ -6.01M |
| 2023 | $ 3.04M | $ -32.61M | $ -42.69M | $ 1.40M | $ -5.05M |
| 2022 | $ 11.17M | $ -34.57M | $ -20.28M | $ 488.7K | $ 11.11M |
| 2021 | $ 0 | $ -46.00M | $ -34.21M | $ 270.5K | $ 38.75M |
| 2020 | $ 0 | $ -34.91M | $ -32.17M | $ 756.8K | $ -1.15M |
| 2019 | $ 0 | $ -18.41M | $ -17.19M | $ 800.5K | $ 440.8K |
| 2018 | $ 0 | $ -22.11M | $ -29.20M | $ 0 | $ 6.73M |
| 2017 | $ 0 | $ -28.61M | $ -3.42M | $ 0 | $ 13.29M |
| 2016 | $ 1.05M | $ -54.08M | $ -46.88M | $ 12.82M | $ 13.11M |
| 2015 | $ 0 | $ -55.59M | $ -45.20M | $ 20.32M | $ 48.74M |
| 2014 | $ 113.0K | $ -32.98M | $ -27.25M | $ 3.12M | $ 45.33M |
| 2013 | $ 8.5K | $ -24.38M | $ -23.64M | $ 6.26M | $ -2.79M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 2.20 |
| Liabilities / Eq | 36.89 |
| Current Ratio | 1.03 |

## Other views

- [Metrics](https://sponda.capital/en/DARE.md)
- [Charts](https://sponda.capital/en/DARE/charts.md)
- [Compare](https://sponda.capital/en/DARE/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.